Back

NOACs in kidney failure: why, how, when and when not?

28 August 2017 (11:00 - 11:22)
Organised by:
Congress Presentation Part of: The use of oral anticoagulants in special situations Drug therapy ESC Premium Access ESC Congress 2017

About the speaker

Photo
Professor Felicita Andreotti

IRCCS Foundation Agostino Gemelli University Hospital, Rome (Italy)

3 More presentations in this session

Presentation thumbnail
NOACs in patients undergoing cardioversion or ablation.
Professor F. Verheugt (Amsterdam, NL)
Slides Video
Presentation thumbnail
NOACs vs vitamine K antagonist in patients with extreme body weights.
Professor J. Collet (Paris, FR)
Slides Video
Presentation thumbnail
Panel discussion: the use of oral anticoagulants in special situations
Video

Access the full session

Session thumbnail
The use of oral anticoagulants in special situations

The Event

Event poster

ESC Congress 2017

28 August 2017 11:00 CET
You may be interested in
thumbnail
Congress Presentation
NOAC patient journey: i.e. bridging, ACS/PCI, renal dysfunction and comedication.
3 April 2022
thumbnail
Congress Presentation
DOAC versus warfarin in patients with atrial fibrillation and stage IV-V chronic kideny disease including patients on dialysis.
27 August 2021
thumbnail
Congress Presentation
Use of Non-vitamin K antagonist Oral Anticoagulants in a real-world setting: a community pharmacy-based study.
31 August 2019
thumbnail
Webinar
Are NOACs already outdated? New trends in anticoagulation therapy
12 December 2022

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources